Assertio (ASRT)
(Delayed Data from NSDQ)
$1.17 USD
-0.04 (-3.31%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $1.18 +0.01 (0.85%) 7:16 PM ET
4-Sell of 5 4
C Value C Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Assertio Holdings, Inc. [ASRT]
Reports for Purchase
Showing records 61 - 80 ( 118 total )
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Expect Better 2Q:22 Results Year-Over-Year As ASRT Benefits From Improved Top Line
Provider: SIDOTI CSR
Analyst: Research Department
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Initiate Coverage Of Assertio Holdings, Inc. With a $6 Price Target And Moderately Risky Rating
Provider: SIDOTI CSR
Analyst: Research Department
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
4Q21 Recap - Solid Results and Emerging Pipeline
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
3Q21 Recap - Potentially Transformational Quarter
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
Company: Assertio Holdings, Inc.
Industry: Medical - Drugs
1Q21 Recap - Stabilizing for Product Acquisitions
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S